0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

TREATMENT OF PNEUMOCOCCAL PNEUMONIA WITH ERYTHROMYCIN AND CARBOMYCIN (MAGNAMYCIN)

PAUL A. BUNN, M.D.; ELLEN COOK, M.D.
AMA Arch Intern Med. 1953;92(3):333-340. doi:10.1001/archinte.1953.00240210037005.
Text Size: A A A
Published online

WITHIN the past nine months two new antimicrobial agents, erythromycin and carbomycin (Magnamycin), have been described and preliminary reports of their clinical use have been published.1 Each has been shown to have in vitro activity of a high order against most Gram-positive bacteria, including the pneumococci. A small study was undertaken, therefore, to test the efficacy of both agents in the initial management of adult patients with proved pneumococcal pneumonia. This report describes the results of the administration of erythromycin to 12 and carbomycin to 8 persons with pneumonia. The series was not enlarged because the results of therapy in both groups were so unsatisfactory that further study was precluded.

METHODS AND MATERIALS  The 20 unselected patients were treated in the general medical wards of the Syracuse Medical Center Hospitals and received similar accessory medical and nursing attention. Infection in the group as a whole was not unusual (Table

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();